Table 4 Risk factors associated with COVID-19 severity

Age

335.0999***

  < 60

579 (0.87)

72 (0.11)

4 (0.01)

1 (0)

9 (0.01)

 61–69

363 (0.71)

115 (0.22)

10 (0.02)

3 (0.01)

23 (0.04)

 70–79

246 (0.59)

113 (0.27)

6 (0.01)

1 (0)

52 (0.12)

  ≥ 80

134 (0.43)

78 (0.25)

4 (0.01)

1 (0)

97 (0.31)

Sex

6.3159

 male

562 (0.67)

174 (0.21)

13 (0.02)

3 (0)

92 (0.11)

 female

760 (0.71)

204 (0.19)

11 (0.01)

3 (0)

89 (0.08)

Diabetes mellitus

40.4894***

 No

683 (0.76)

151 (0.17)

11 (0.01)

3 (0)

54 (0.06)

 yes

639 (0.63)

227 (0.22)

13 (0.01)

3 (0)

127 (0.13)

Cardiovascular disease

1.1868

 No

1255 (0.69)

357 (0.2)

22 (0.01)

6 (0)

170 (0.09)

 Yes

67 (0.66)

21 (0.21)

2 (0.02)

0 (0)

11 (0.11)

Cerebrovascular disease

24.6214***

 No

1158 (0.71)

309 (0.19)

22 (0.01)

6 (0)

137 (0.08)

 Yes

164 (0.59)

69 (0.25)

2 (0.01)

0 (0)

44 (0.16)

Ischemic heart disease

8.4676

 No

1204 (0.7)

334 (0.19)

20 (0.01)

6 (0)

155 (0.09)

 Yes

118 (0.61)

44 (0.23)

4 (0.02)

0 (0)

26 (0.14)

COPD

12.8381*

 No

1300 (0.7)

363 (0.19)

24 (0.01)

6 (0)

172 (0.09)

 Yes

22 (0.48)

15 (0.33)

0 (0)

0 (0)

9 (0.2)

Malignancy

11.4142*

 No

1241 (0.7)

348 (0.2)

22 (0.01)

6 (0)

158 (0.09)

 Yes

81 (0.6)

30 (0.22)

2 (0.01)

0 (0)

23 (0.17)

Renal replacement therapy

18.3735***

 No

1315 (0.7)

367 (0.19)

24 (0.01)

6 (0)

176 (0.09)

 Yes

7 (0.3)

11 (0.48)

0 (0)

0 (0)

5 (0.22)

ARB/ACEI use before

COVID-19 diagnosis

0.5448

 No

1094 (0.69)

310 (0.2)

19 (0.01)

5 (0)

152 (0.1)

 Yes

228 (0.69)

68 (0.21)

5 (0.02)

1 (0)

29 (0.09)

ARB/ACEI use after

COVID-19 diagnosis

8.7247

 No

1259 (0.6)

355 (0.2)

21 (0.01)

5 (0)

177 (0.1)

 Yes

63 (0.67)

23 (0.24)

3 (0.03)

1 (0.01)

4 (0.04)